(Press-News.org) A new study determined that African Americans who smoke cigarettes have a higher risk of developing rheumatoid arthritis (RA). RA risk is more pronounced among individuals positive for the HLA-DRB1 shared epitope, a genetic risk factor for RA. Findings from this study—the largest to date examining the impact of smoking on RA risk in an African American population—are available in the December issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).
RA is a chronic inflammatory disease that affects the joint lining (synovial membrane) and causes pain, swelling and redness in the joints. The ACR estimates that 1.3 million Americans are diagnosed with RA and 75% of those are women. Prior studies suggest cigarette smoking may be associated with increased risk of developing RA. A 2009 health report compiled by the Centers for Disease Control and Prevention estimate that in the African American population, 26% of men and 17% of women 18 years of age and older smoke.
"RA epidemiology has been largely understudied in the African American population," explained Ted Mikuls, MD, MSPH, from the University of Nebraska Medical Center and lead study author. "The aim of our study was to bridge the knowledge gap by determining whether smoking contributes to RA risk in African Americans and define the extent to which this association is affected by genetic risk."
The current study evaluated participants with RA (605) and healthy controls (255) from the Consortium for the Longitudinal Evaluations of African Americans with Early Rheumatoid Arthritis (CLEAR) I study group (RA patients with less than two years disease duration from the time of symptom onset) and the CLEAR II study group (RA patients with any disease duration). Researchers analyzed smoking status (current, former, never), cumulative smoking exposure and genetic risk factor (HLA-DRB1 shared epitope (SE)).
Results showed that patients with RA were slightly more likely to report a status of former or current smoker and less likely to be never smokers than healthy subjects. Heavy smoking (greater than 10 pack-years) was found in 54% of RA patients and in 35% of controls who ever smoked. Researchers also found that RA patients were more likely than controls to have at least one HLA-DRB1 SE-containing allele (40% versus 23%).
"We found a two-fold increase in RA risk among African Americans who were heavy smokers, and this risk increased to more than four-fold in the presence of SE alleles," commented Dr. Mikuls. "Our results suggest that roughly one in six new cases of RA occurring in African Americans could be prevented through smoking cessation or by limiting cumulative smoking exposure to less than 10 pack-years."
INFORMATION:
This study is published in Arthritis & Rheumatism. Media wishing to receive a PDF of the article may contact healthnews@wiley.com.
Full Citation: "Associations of Cigarette Smoking With Rheumatoid Arthritis in African Americans." Ted R. Mikuls, Harlan Sayles, Fang Yu, Tricia LeVan, Karen A. Gould, Geoffrey M. Thiele, Doyt L. Conn, Beth L. Jonas, Leigh F. Callahan, Edwin Smith, Richard Brasington, Larry W. Moreland, Richard J. Reynolds, and S. Louis Bridges, Jr. Arthritis & Rheumatism; Published Online: August 18, 2010 (DOI: 10.1002/art.27716); Print Issue Date: December 2010. http://onlinelibrary.wiley.com/doi/10.1002/art.27716/abstract.
About the Journal
Arthritis & Rheumatism is an official journal of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP), a division of the College, and covers all aspects of inflammatory disease. The American College of Rheumatology (www.rheumatology.org) is the professional organization who share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers. For details, please visit http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1529-0131.
About Wiley-Blackwell
Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com or our new online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.
END
Positive outcomes in rheumatoid arthritis (RA) are closely linked to early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDs). A study by researchers in the Netherlands found that patients who are assessed by rheumatologists soon after RA symptoms appear are more likely to experience less joint destruction and improved chances of DMARD-free disease remission. Details of this novel study are published in the December issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.
The World Health Organization (WHO) estimates ...
Scientists at The University of Nottingham have made a major breakthrough that could help shape the future of nanotechnology, by demonstrating for the first time that 3-D molecular structures can be built on a surface.
The discovery could prove a significant step forward towards the development of new nano devices such as cutting-edge optical and electronic technologies and even molecular computers.
In a paper published in the prestigious journal Nature Chemistry, the team of chemists and physicists at Nottingham have shown that by introducing a 'guest' molecule they ...
A team of Australian researchers involving DNA experts from the University of Adelaide has identified a new, critically endangered species of ground parrot in Western Australia.
The team, led by Australian Wildlife Conservancy's Dr Stephen Murphy, used DNA from museum specimens up to 160 years old to reveal that populations of ground parrots in eastern and western Australia are highly distinct from each other and that the western populations should be recognized as a new species, Pezoporus flaviventris.
"The discovery has major conservation implications," said Dr Murphy. ...
Putting tobacco out of sight in shops can change the attitude of young people to smoking, while not hitting retailers in the pocket, researchers at The University of Nottingham have discovered.
Academics from the University's UK Centre for Tobacco Control Studies looked at the effect of the removal of tobacco displays in the Republic of Ireland, ahead of similar legislation which is due to come into force in the UK. The findings are published today in the journal Tobacco Control.
In one study the research team found that the number of teenagers who recalled tobacco ...
St. Louis, MO, 23 November, 2010 – Proper nutrition therapy is essential for the successful management of type 1 and type 2 diabetes and registered dietitians (RDs) can play a key role as part of the health care team. An article in the December issue of the Journal of the American Dietetic Association reviews the evidence and nutrition practice recommendations presented in the American Dietetic Association Nutrition Practice Guidelines for Type 1 and Type 2 Diabetes in Adults. This complete and systematic review presents 29 key nutrition practice guidelines in order to ...
A daily dose of an oral antiretroviral drug, currently approved to treat HIV infection, reduced the risk of acquiring HIV infection by 43.8 percent among men who have sex with men. The findings, a major advance in HIV prevention research, come from a large international clinical trial published online Nov. 23 by the New England Journal of Medicine. The study, titled "Chemoprophylaxis for HIV Prevention in Men," found even higher rates of effectiveness, up to 72.8 percent, among those participants who adhered most closely to the daily drug regimen.
"We now have strong ...
A research team led by the University of Bristol has used STFC's ISIS Neutron Source to come up with a new way to treat carbon dioxide (CO2), so that it can be used in efficient and environmentally friendly methods for extracting oil. These new CO2 soluble additives can also be used to reduce the environmental damage caused by every day industrial processes such as food processing and the manufacture of electronics. The results of this work are published in the journal Langmuir.
The researchers have developed a soap-like additive for CO2 that turns it into a viable solvent ...
(San Francisco, CA) – In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofovir (FTC/TDF), experienced an average of 43.8% fewer HIV infections than those who received a placebo pill (95% CI 15.4 to 62.6%; P=0.005). The study, reported in the New England Journal of Medicine, is the first evidence that this new HIV prevention method, called pre-exposure ...
BOSTON (Nov. 23, 2010) —Breast cancer stem cells (CSCs), the aggressive cells thought to be resistant to current anti-cancer therapies and which promote metastasis, are stimulated by estrogen via a pathway that mirrors normal stem cell development. Disrupting the pathway, researchers were able to halt the expansion of breast CSCs, a finding that suggests a new drug therapy target. The study, done in mice, is published in the Proceedings of the National Academy of Sciences (PNAS) Early Edition this week.
"A critical aspect of our work was to discover that estrogen could ...
ARLINGTON, VA-- NOVEMBER 23, 2010 - - CONRAD is pleased to join in congratulating the Global iPrEx study team for their successful trial of oral tenofovir (TDF) with emtricitabine (FTC) for HIV prevention. Results of the National Institutes of Health (NIH) sponsored study were announced today in the New England Journal of Medicine. Daily use of the widely used antiretroviral combination pill was found to be an average of 44% effective in reducing risk of HIV infection in men who have sex with men (MSM), a historically high risk population. Among participants who took ...
